LS9, Inc., a startup founded in 2005 to apply synthetic biology technology to the production of proprietary biofuels (earlier post), has named Robert Walsh its new President, effective immediately. Walsh will lead the rapid commercialization of LS9 DesignerBiofuels products, including a pilot facility leading to commercial production.
LS9 DesignerBiofuels products are a family of fuels produced by microbes that have been specially engineered via recently developed methods of industrial synthetic biology. LS9 hydrocarbon biofuels have higher energetic content than ethanol or butanol and have fuel properties that are essentially indistinguishable from those of gasoline, diesel, and jet fuel.
One of the company’s products is a Designer Biodiesel that overcomes the key challenges associated with existing vegetable oil-based biodiesel including quality consistency, scalability of feedstocks, product economics, and cold-flow properties.
Walsh brings more than 28 years of global petroleum industry experience including 26 years at Royal Dutch Shell. From 2001 to 2005, he was General Manager Supply for Shell Europe Oil Products where he was responsible for $30 billion in annual revenue.
After years of leadership roles in the traditional petroleum industry and responsibility over all aspects of the hydrocarbon supply chain, I can see clearly how LS9's products will fit into existing infrastructure and deliver significant value to partners and consumers compared with other biofuel alternatives. LS9 has the opportunity to fundamentally change the transportation fuel equation.—Robert Walsh
Walsh replaces Doug Cameron of Khosla Ventures who has been acting CEO of the company during the past year. Dr. Cameron will remain actively involved with LS9 as a Board member as well as a member of its Scientific Advisory Board.